Tech Company Financing Transactions

GeneAssess Funding Round

On 7/3/2012, GeneAssess received $500 thousand in funding from Foundation Venture Capital Group.

Transaction Overview

Company Name
Announced On
7/3/2012
Transaction Type
Venture Equity
Amount
$500,000
Round
Undisclosed
Investors
Proceeds Purpose
GeneAssess plans to use the investment to validate FRY as a predictive biomarker for breast and other cancers, to detect genetic mutations in at-risk populations and to explore target validation for FRY.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
New Brunswick, NJ 08901
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
GeneAssess plans to validate FRY as a predictive biomarker for breast and other cancers, to detect genetic mutations in at-risk populations and to explore target validation for FRY.
Profile
GeneAssess LinkedIn Company Profile
Social Media
GeneAssess Company Twitter Account
Company News
GeneAssess News
Facebook
GeneAssess on Facebook
YouTube
GeneAssess on YouTube

Management Team

Title
Name
Email & Social
Founder
Helmut Zarbl
  Helmut Zarbl LinkedIn Profile  Helmut Zarbl Twitter Account  Helmut Zarbl News  Helmut Zarbl on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/3/2012: Narrative Science venture capital transaction
Next: 7/3/2012: ConnectYard venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document tech company VC transactions. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary